Clinical Microbiology Newsletter RSS feed: Current Issue. Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a “benchmark” for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones. Clinical Microbiology Newsletter brings you: – minireviews on pathogenesis, diagnosis, epidemiology, therapy of infectious diseases – practical and brief articles on laboratory techniques – indispensable updates on important clinical problems – editorials and opinions on controversial issues in laboratory medicine – helpful tips on improving the laboratory workplace – instructive case reports that describe or resolve difficult or unusual clinical cases. In these days of cost containment and high expectations, Clinical Microbiology Newsletter can help you streamline procedures and improve results.http://www.cmnewsletter.com/?rss=yesElsevier Inc.en © 2010 Elsevier Inc. All rights reserved. Clinical Microbiology Newsletter0196-4399321215 June 2010 © 2010 Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.cmnewsletter.com/article/PIIS0196439910000279/abstract?rss=yesAbstract: Infections caused by Streptococcus suis are an important economic problem in the swine industry. Moreover, S. suis (especially serotype 2) is an agent of zoonosis that has the potential to afflict those who are in close contact with infected pigs or pork-derived products. Although sporadic cases of S. suis infections in humans have been reported during the last 40 years, a large outbreak in China emerged in 2005. The severity of the infection in humans during the outbreak, such as clinical signs of streptococcal toxic shock syndrome, attracted much attention from the scientific community and the public press. This two-part review will focus on this organism and the infections it causes, highlighting the differences between Asian and Western countries, particularly with respect to its epidemiology. In part I, the general characteristics of the organism are reviewed, as well as the clinical characteristics associated with S. suis infection in humans, the pathogenesis of infection and associated virulence factors, and, finally, the interactions between S. suis and the host's immune system. Streptococcus suis Infections in Humans: What is the prognosis for Western countries? (Part I)Marcelo Gottschalk, Jiangu Xu, Marie-Pier Lecours, Daniel Grenier, Nahuel Fittipaldi, Mariela Segura10.1016/j.clinmicnews.2010.05.005Clinical Microbiology Newsletter 32, 12 (2010)2010-06-15Clinical Microbiology Newsletter2010-06-153212S0196-4399(10)X0011-38996